Vitro Biopharma, Inc. Quarterly Accounts Payable, Current in USD from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Vitro Biopharma, Inc. quarterly Accounts Payable, Current history and growth rate from Q3 2012 to Q2 2024.
  • Vitro Biopharma, Inc. Accounts Payable, Current for the quarter ending July 31, 2024 was $2.32M.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.32M Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $2.18M +$1.26M +138% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $2.21M +$1.35M +156% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $2.29M +$1.68M +279% Oct 31, 2023 10-Q 2024-09-16
Q1 2023 $917K Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $862K Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $605K Oct 31, 2022 10-Q 2023-06-13
Q3 2015 $63.8K +$15.8K +33% Oct 31, 2015 10-K 2016-09-22
Q2 2015 $61.9K +$20.2K +48.3% Jul 31, 2015 10-Q 2016-03-30
Q1 2015 $64.1K +$13.9K +27.6% Apr 30, 2015 10-Q 2016-01-22
Q4 2014 $36.2K +$13.7K +60.7% Jan 31, 2015 10-Q 2015-03-24
Q3 2014 $48K +$19.7K +69.9% Oct 31, 2014 10-K 2016-09-22
Q2 2014 $41.8K +$5.6K +15.5% Jul 31, 2014 10-Q 2014-09-22
Q1 2014 $50.3K -$2.3K -4.37% Apr 30, 2014 10-Q 2014-06-19
Q4 2013 $22.6K Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $28.2K -$9.79K -25.7% Oct 31, 2013 10-K 2015-02-13
Q2 2013 $36.2K Jul 31, 2013 10-Q 2013-09-23
Q1 2013 $52.6K Apr 30, 2013 10-Q 2013-06-18
Q3 2012 $38K Oct 31, 2012 10-K 2014-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.